Lv7
4780 积分 2021-08-07 加入
A phase 2 study of zanubrutinib in combination with rituximab and lenalidomide in de novo diffuse large B-cell lymphoma
10天前
已完结
Bispecific antibodies followed by allogeneic hematopoietic stem cell transplantation as rescue therapy in refractory/relapsed B cell non-Hodgkin lymphoma: a real-life experience
13天前
已完结
Accumulation of high-risk genetic features after chemoimmunotherapy: A longitudinal study in mantle cell lymphoma
1个月前
已完结
Rehabilitation difficulties
2个月前
已完结
Treatment approaches for patients with TP53-mutated mantle cell lymphoma
2个月前
已完结
Zanubrutinib, obinutuzumab, and venetoclax for first-line treatment of mantle cell lymphoma with a TP53 mutation
2个月前
已完结
Frontline management of mantle cell lymphoma
2个月前
已完结
Chimeric antigen receptor T-cell therapy and bispecific antibody sequence for large B-cell lymphoma: a systematic review and meta-analysis
2个月前
已完结
What is the best salvage therapy for Hodgkin lymphoma?
3个月前
已完结
Impact of immunochemotherapy regimens on outcomes of patients with primary mediastinal B-cell lymphoma in the IELSG37 trial
3个月前
已完结
皖公网安备34019202002308
